newsfilter
← Latest News
GlobeNewswire·

Serina Therapeutics Receives NYSE Deficiency Notification Regarding Shareholders' Equity

HUNTSVILLE, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. ("Serina" or the "Company") (NYSE:SER), a clinical-stage biotechnology company advancing its lead Investigational New Drug ("IND")